TY  - CHAP
M1  - Book, Section
TI  - Miller Fisher Syndrome
A1  - Bissonnette, Bruno
A1  - Luginbuehl, Igor
A1  - Engelhardt, Thomas
Y1  - 2019
N1  - 
T2  - Syndromes: Rapid Recognition and Perioperative Implications, 2e
AB  - It  is  a  rare  and  acquired  nerve  disease  considered  to  be  a  variant  of  the  Guillain-Barré  Syndrome.  It  is  characterized  by  abnormal  muscle  coordination,  ophthalmoplegia,  and  tendon  areflexia.  As  with  Guillain-Barré  Syndrome,  the  symptoms  may  be  preceded  by  a  viral  illness.  Other  clinical  features  include  generalized  muscle  weakness  and  respiratory  failure.  The  prognosis  is  good,  with  recovery  beginning  within  2  to  4  weeks  and  almost  completed  within  6  months.  Residual  neurologic  deficits  may  occur,  and  relapses  occur  in  less  than  3%  of  individuals  affected.  The  majority  of  individuals  with  Miller  Fisher  Syndrome  have  a  unique  antibody  that  characterizes  the  disorder.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/25
UR  - accesspediatrics.mhmedical.com/content.aspx?aid=1164078784
ER  -